Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose. We are headquartered in Santa Monica, with additional offices in London, UK. We were founded in 2009. In 2013, Opiant developed the first FDA-approved, user-friendly nasal naloxone spray.
In 2015 this product, NARCAN(R) Nasal Spray 4mg, became available in the United States and Canada through our commercial partner, Adapt Pharma (now a part of Emergent BioSolutions). Opiant is now focused on advancing its pipeline alongside receiving royalties from NARCAN(R) Nasal Spray. In addition to NARCAN(R) Nasal Spray, we are developing medicines for addictions and drug overdose.
In 2015 this product, NARCAN(R) Nasal Spray 4mg, became available in the United States and Canada through our commercial partner, Adapt Pharma (now a part of Emergent BioSolutions). Opiant is now focused on advancing its pipeline alongside receiving royalties from NARCAN(R) Nasal Spray. In addition to NARCAN(R) Nasal Spray, we are developing medicines for addictions and drug overdose.
Services
In a world where addictions remain highly stigmatized diseases, we aim to reverse that view. Together, we can develop medicines that treat addictions as chronic brain diseases rather than character flaws. Every day, the people at Opiant work tirelessly towards a common goal - to improve and save the lives of patients afflicted by addictions and drug overdose.
Like other addictions, Alcohol Use Disorder (AUD) is a chronic, relapsing brain disease. AUD is generally characterized by compulsive drinking, an inability to control intake despite negative social or economic consequences, and a negative emotional and physical state when not consuming alcohol. People diagnosed with AUD can still be functional, with their level of functionality dependent upon the severity of their disorder.
Opiant Pharmaceuticals was founded with the goal of creating pharmacotherapies to treat addictions and drug overdose. Most current addiction treatments are ineffective and for patients and families, definitive treatment options cannot happen fast enough. Having a loved one or living oneself with addiction is an affliction difficult to fathom.
Reviews
Be the first to review Opiant Pharmaceuticals.
Write a Review
